India to Pakistan: Imatinib Export Trade Route

The India to Pakistan Imatinib corridor is one of India's established pharmaceutical export routes, with 52 shipments documented worth a combined $3.2M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's imatinib manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $62.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with imatinib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 30 days port-to-port. The route has recorded an annual growth rate of 26.0%, placing it at rank #10 among India's top imatinib export destinations globally.

On the import side, key buyers of Indian imatinib in Pakistan include HABIB BANK LIMITED, JS BANK LTD., TO THE ORDER OF JS BANK LTD and 5 others. HABIB BANK LIMITED is the single largest importer with 15 shipments valued at $1.3M USD.

India's imatinib exports to Pakistan are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 48 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Pakistan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, CIPLA LIMITED , MASCOT INDUSTRIES — together account for 100% of total trade value on this route. The average shipment value of $62.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as imatib alpha 100 capsules (imatinib capsules 100mg) (1x10's x11880pack=118800num) and imatib alpha 100 capsules ( imatinib capsules 100 mg ) (inv.qty.61350 pack 1x10s=613500 nos), suggesting that buyers in Pakistan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, HABIB BANK LIMITED is the largest importer with 15 shipments worth $1.3M USD — representing 40% of all imatinib imports from India on this route. A total of 8 buyers are active on this corridor.